Inoculation Site from a Cutaneous Melanoma Patient Treated with an Allogeneic Therapeutic Vaccine: A Case Report

We have developed a therapeutic vaccine consisting of a mixture of lethally-irradiated allogeneic cutaneous melanoma cell lines with BCG and GM-CSF as adjuvants. The CSF-470 vaccine is currently being assayed in a Phase II–III trial against medium-dose IFN-α2b. All vaccinated patients immunized intr...

Full description

Saved in:
Bibliographic Details
Published in:Front Immunol
Main Authors: Aris, Mariana, Bravo, Alicia Inés, Barrio, María Marcela, Mordoh, José
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2015
Subjects:
Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4378302/
https://ncbi.nlm.nih.gov/pubmed/25870600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2015.00144
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items